35. Pemphigus
87 clinical trials,   114 drugs   (DrugBank: 37 drugs),   17 drug target genes,   158 drug target pathways

Searched query = "Pemphigus"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01930175
(ClinicalTrials.gov)
December 18, 201323/8/2013Study of Efficacy and Safety of VAY736 in Patients With Pemphigus VulgarisA Randomized, Partial-blind, Placebo-controlled Trial Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of VAY736 in the Treatment of Patients With Pemphigus VulgarisPemphigus VulgarisDrug: VAY736;Drug: PlaceboNovartis PharmaceuticalsNULLTerminated20 Years70 YearsAll13Phase 2United States;Austria;Bulgaria;Taiwan;Germany;Israel;Italy;United Kingdom
2EUCTR2013-001217-33-AT
(EUCTR)
25/11/201303/10/2013Study of efficacy and safety of VAY736 in patients with Pemphigus vulgarisA randomized, partial-blind, placebo-controlled trial evaluating the efficacy, safety, pharmacokinetics and pharmacodynamics of VAY736 in the treatment of patients with pemphigus vulgaris Pemphigus vulgaris
MedDRA version: 20.0;Level: LLT;Classification code 10052802;Term: Pemphigus vulgaris;System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
Novartis Pharma Services AGNULLNot Recruiting Female: yes
Male: yes
32Phase 2United States;Taiwan;Austria;Bulgaria